logo

Lannett Co Inc (LCI)



Trade LCI now with
  Date
  Headline
7/29/2021 6:54:11 AM LANNETT Signs Exclusive Distribution Agreement For Generic SPIRIVA Handihaler
7/12/2021 6:54:10 AM Lannett Launches Fluvastatin Sodium ER Tablets
7/12/2021 6:52:00 AM Lannett Launches Fluvastatin Sodium ER Tablets (Press Release)
5/27/2021 11:24:26 PM Organon Set To Join S&P 500
4/9/2021 6:54:13 AM Lannett Announces Pricing Of $350 Mln Senior Secured Notes Due 2026 In A Private Placement To Institutional Buyers
4/6/2021 7:23:40 AM Lannett Intends To Offer $350 Mln Senior Notes Due 2026 In A Private Placement To Qualified Institutional Buyers
4/1/2021 8:32:04 AM Lannett Submits ANDA For Generic ADVAIR DISKUS
3/10/2021 7:01:02 AM Lannett Recently Receivesfeedback From FDA Regarding Biosimilar Insulin Glargine
2/9/2021 6:54:50 AM Lannett Adds New Co-development Agreement For Biosimilar Insulin
2/8/2021 6:53:28 AM Lannett Begins Marketing Chlorpromazine Hydrochloride Tablets
11/30/2020 6:54:46 AM Lannett Says It Used Portion Of Existing Cash On Hand To Pay Off Remaining $42 Mln Outstanding Balance Of Term A Loans
11/3/2020 6:55:49 AM Lannett Launches Authorized Generic Of Tirosint
8/26/2020 4:33:23 PM Lannett Q4 Loss/share $0.25 Vs. Loss $0.20 Year Ago
8/17/2020 7:05:38 AM Lannett Enters Exclusive US Distribution Deal For Therapeutically Equivalent Generic Of Flovent Diskus Of Respirent
8/3/2020 6:54:13 AM Lannett Announces Launch Of FDA Approved Levothyroxine Tablets